The iconic rise of Viagra presented a massive opportunity for the market, but its period has expired , creating a complex landscape. Alternative versions have flooded the market , cutting into profits and putting a squeeze on profit yields. While leading pharmaceutical companies hold a stake in this sector , the outlook remains ambiguous by fierce